Hot Pursuit     04-Jul-24
Zydus Lifesciences Ltd spurts 2.26%, rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 1119.95, up 2.26% on the day as on 12:49 IST on the NSE. The stock is up 91.44% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 1119.95, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Zydus Lifesciences Ltd has added around 6.8% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 13.33 lakh shares today, compared to the daily average of 15.07 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1125.9, up 2.2% on the day. Zydus Lifesciences Ltd is up 91.44% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

The PE of the stock is 31.94 based on TTM earnings ending March 24.

Previous News
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus Life gets tentative USFDA nod for hypertension drugs
 ( Hot Pursuit - 14-Jun-24   12:34 )
  Zydus Life gets US FDA nod for anti-cancer medication Cyclophosphamide
 ( Hot Pursuit - 14-Dec-23   14:31 )
  Zydus receives USFDA final approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Dec-23   18:57 )
  Zydus Lifesciences launches cancer drug - IBYRA in India
 ( Corporate News - 13-Mar-24   16:31 )
  Zydus Lifesciences Ltd soars 1.23%, gains for fifth straight session
 ( Hot Pursuit - 21-May-24   13:00 )
  Zydus enters into licensing and supply agreement with MSN Laboaratories
 ( Corporate News - 17-May-24   09:07 )
  Zydus receives USFDA approval for Minocycline Hydrochloride ER Tablets
 ( Corporate News - 19-Jun-23   15:41 )
  Zydus Life gets USFDA nod for breast cancer drug
 ( Hot Pursuit - 29-Jun-23   12:17 )
  Zydus partners with Lupin to market Saroglitazar Mg in India
 ( Corporate News - 03-Nov-23   14:46 )
  Zydus Life Ahmedabad unit gets 6 observations
 ( Hot Pursuit - 23-Dec-23   15:08 )
Other Stories
  Shalby drops after PAT slides 20% YoY to Rs 16 cr in Q1 FY25
  08-Jul-24   16:01
  Tata Steel Production rises 5% YoY in Q1 FY24
  08-Jul-24   15:54
  PC Jeweller soars after PNB approves settlement
  08-Jul-24   15:26
  Godrej Inds gains after chemicals arm inks BTA to acquire Ethoxylation Unit II
  08-Jul-24   15:22
  GE Power sizzles after NTPC order win
  08-Jul-24   15:02
  Patel Engineering Ltd leads losers in 'A' group
  08-Jul-24   15:01
  Sundaram Multi Pap Ltd leads losers in 'B' group
  08-Jul-24   14:46
  Marine Electricals jumps after order win
  08-Jul-24   14:33
  Volumes soar at Metro Brands Ltd counter
  08-Jul-24   14:30
  Bank of India Q1 domestic deposits grow 10% YoY
  08-Jul-24   14:25
Back Top